Apotea AB (publ) (CHIX:APOTES) YoY EPS Growth: 13.04% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
16 GF Score
Price kr76.83
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) YoY EPS Growth?

Apotea AB (publ) CHIX:APOTES 16 YoY EPS Growth is 13.04% as of Jun. 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Apotea AB (publ)'s YoY EPS Growth for the quarter that ended in Jun. 2026 was 13.04%.

Apotea AB (publ)'s Earnings per Share (Diluted) for the three months ended in Jun. 2026 was kr0.78.

Apotea AB (publ) YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) YoY EPS Growth Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
0.00 -81.05 337.70 150.00 5.26

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.76 24.07 -68.75 10.14 13.04
CHIX:APOTES
16GF Score
Apotea AB (publ) CHIX:APOTES
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Apotea AB (publ)'s YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(2.2-2.09)/ | 2.09 |
=5.26 %

Apotea AB (publ)'s YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(0.78-0.69)/ | 0.69 |
=13.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 13.04% mean?
Apotea AB (publ) (CHIX:APOTES) has a YoY EPS Growth of 13.04% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s YoY EPS Growth too high?
Apotea AB (publ)'s current YoY EPS Growth is 13.04%. Overall, Apotea AB (publ) has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s YoY EPS Growth compare to competitors?
Apotea AB (publ)'s YoY EPS Growth of 13.04% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Apotea AB (publ) and its competitors. Apotea AB (publ)'s current YoY EPS Growth is 13.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current YoY EPS Growth of 13.04%. The current YoY EPS Growth is 13.04%. Apotea AB (publ)'s overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current YoY EPS Growth is 13.04% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
16GF Score

Get the complete analysis for CHIX:APOTES

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr76.83
Price